Related by context. Frequent words. (Click for all words.) 67 Juergen Engel Ph.D. 64 Æterna Zentaris 63 Dr. Randall Yatscoff 62 ACADIA Pharmaceuticals 62 Flamel Technologies 61 Declares Dividend Quick Facts 61 Genaera Corporation 61 Nasdaq ADLR 61 Larry W. Reaugh 61 Steve Worland Ph.D. 60 ABAXIS 60 Guides FY# Quick Facts 60 Inc. Nasdaq IMGN 60 Ben Lipps 60 Kiadis Pharma 60 NASDAQ IPXL today 60 Emisphere Technologies 60 Brian JG Pereira 60 Arthur S. Przybyl 60 Regado Biosciences 60 Jumps Higher 60 AEterna 60 Daxor 59 Pyng Medical 59 Paris IPN 59 ICON plc 59 Attracting Bullish Investors 59 Senesco Technologies 59 ALTANA AG 59 Senetek PLC 59 Receives Orphan Drug Designation 59 Morgan J. Poliquin 59 Nutra Pharma Corporation 59 Active Biotech AB 58 Inovio Pharmaceuticals 58 Gilles Gagnon 58 Idera Pharmaceuticals 58 CardioVascular BioTherapeutics Inc. 58 Applied NeuroSolutions 58 Michael H. Tardugno 58 ARQL 58 MDTH 58 Cerus Corporation 58 Dominique Doucet 58 Diatos 58 FluoroPharma 58 Nasdaq ENZN 58 Metabasis Therapeutics Inc. 58 Exploit collaboration 58 Simon Sturge 58 SANOFI AVENTIS 58 Discusses Q4 57 Welcomes Analyst Initiation 57 Oroco Resource Corp. 57 PhytoMedical Technologies Inc. 57 RDEA 57 Eamonn Hobbs 57 Hold Third Quarter 57 Masimo Corporation 57 Affymax Inc. 57 Acrongenomics Inc. 57 Discusses Q3 57 Novadaq Technologies Inc. 57 www.vivus.com 57 Evotec AG 57 Files Shelf Registration Statement 57 Q2 Loss Narrows 57 Quark Pharmaceuticals 57 Earnings Postmortem 57 Q1 Loss Narrows 57 Biotie Therapies Corp. 56 Accuray Incorporated 56 J. Donald deBethizy 56 ExonHit Therapeutics 56 Photocure 56 Sol J. Barer 56 OSI Prosidion 56 Dino Dina 56 Chief ExecutiveOfficer 56 DeveloGen 56 AviaraDx 56 Q3 Loss Narrows 56 Adolor Corporation 56 Clavis Pharma 56 SUCCEED trial 56 LGL Group 56 Addex Pharmaceuticals 56 Senesco Technologies Inc. 56 AMSG 56 Hyperion Therapeutics 56 ONCOLOGY 56 Celmed 55 FzioMed 55 Mr. Rosconi 55 Keryx Biopharmaceuticals 55 Estracure 55 GammaCan 55 THALOMID 55 Ventiv Health 55 Response Genetics 55 Nanobiotix